BD Biosciences' reagent and dye expansion program launches with flow cytometry antibodies

AUGUST 17, 2009--BD Biosciences (San Jose, CA), a segment of BD (Becton, Dickinson and Company) has launched its BD Kaleidoscope reagent and dye expansion program with the release of nearly 200 new fluorochrome-conjugated antibodies for multicolor flow cytometry. The 200 new products represent "simply the beginning of our significant portfolio expansion designed to support the growing base of applications that can benefit from this powerful technology," the company says.

AUGUST 17, 2009--BD Biosciences (San Jose, CA), a segment of BD (Becton, Dickinson and Company) has launched its BD Kaleidoscope reagent and dye expansion program with the release of nearly 200 new fluorochrome-conjugated antibodies for multicolor flow cytometry. "These 200 new products from the BD Kaleidoscope program represent simply the beginning of our significant portfolio expansion designed to support the growing base of applications that can benefit from this powerful technology," said BD Biosciences' president for cell analysis, Jay Glasscock.

More in Biomedicine